Payment overview · 2025
General Payments
$4,099.36
83 reported records · 20 companies
Healthcare provider profile · identity verified
Vishal Sachdev, M.D.
Allopathic & Osteopathic Physicians|Thoracic Surgery (Cardiothoracic Vascular Surgery) · TUPELO, MS · NPI 1538169503
Verified facts
What the public records show
CMS Open Payments records show Vishal Sachdev, M.D. received $4,099.36 in general payments during 2025 across 83 reported records.
INTUITIVE SURGICAL, INC. accounted for 32.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 32 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| INTUITIVE SURGICAL, INC. | Unresolved — no canonical attribution shown | $1,336.17 | 32.6% | 12 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $470.52 | 11.5% | 7 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $461.28 | 11.2% | 13 | 2025 |
| Surgical Specialties Corporation (us), Inc. (dba Corza Medical) | Unresolved — no canonical attribution shown | $383.91 | 9.4% | 7 | 2025 |
| AtriCure, Inc. | Unresolved — no canonical attribution shown | $290.81 | 7.1% | 8 | 2025 |
| ABIOMED | Unresolved — no canonical attribution shown | $274.57 | 6.7% | 8 | 2025 |
| Edwards Lifesciences Corporation | Unresolved — no canonical attribution shown | $233.34 | 5.7% | 6 | 2025 |
| Artivion, Inc. | Unresolved — no canonical attribution shown | $135.43 | 3.3% | 3 | 2025 |
| Zimmer Biomet Holdings, Inc. | Unresolved — no canonical attribution shown | $103.40 | 2.5% | 1 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$101.56 | 2.5% | 4 | 2025 |
| Corcym Inc | Unresolved — no canonical attribution shown | $53.44 | 1.3% | 2 | 2025 |
| Dilon Technologies, Inc. | Unresolved — no canonical attribution shown | $44.90 | 1.1% | 2 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $44.50 | 1.1% | 2 | 2025 |
| LeMaitre Vascular, Inc. | Unresolved — no canonical attribution shown | $38.15 | 0.9% | 2 | 2025 |
| Merck Sharp & Dohme LLC | Unresolved — no canonical attribution shown | $26.52 | 0.7% | 1 | 2025 |
| Octapharma USA, Inc. | Unresolved — no canonical attribution shown | $24.97 | 0.6% | 1 | 2025 |
| LSI SOLUTIONS INC | Unresolved — no canonical attribution shown | $20.94 | 0.5% | 1 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $20.91 | 0.5% | 1 | 2025 |
| AngioDynamics, Inc. | Unresolved — no canonical attribution shown | $17.19 | 0.4% | 1 | 2025 |
| Kerecis Limited | Unresolved — no canonical attribution shown | $16.85 | 0.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $3,205.69 | 78 |
| Travel and Lodging | $893.67 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Da Vinci Surgical System Normalized: da vinci surgical system |
Device | INTUITIVE SURGICAL, INC. | $1,336.17 | 12 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Stent Normalized: enroute transcarotid stent |
Device | Boston Scientific Corporation | $395.95 | 5 | 2025 |
Source payment records
|
|||||
| SYNERGY ABLATION SYSTEM Normalized: synergy ablation system |
Device | AtriCure, Inc. | $252.52 | 5 | 2025 |
Source payment records
|
|||||
| XACT Normalized: xact |
Device | Abbott Laboratories | $247.39 | 2 | 2025 |
Source payment records
|
|||||
| NAVITOR Normalized: navitor |
Device | Abbott Laboratories | $209.74 | 4 | 2025 |
Source payment records
|
|||||
| AMDS-Ascyrus Medical Normalized: amds ascyrus medical |
Device | Artivion, Inc. | $135.43 | 3 | 2025 |
Source payment records
|
|||||
| ATRICLIP LAA EXCLUSION SYSTEM Normalized: atriclip laa exclusion system |
Device | AtriCure, Inc. | $110.28 | 4 | 2025 |
Source payment records
|
|||||
| RIBFIX BLU ADVANTAGE Normalized: ribfix blu advantage |
Device | Zimmer Biomet Holdings, Inc. | $103.40 | 1 | 2025 |
Source payment records
|
|||||
| RIBFIX TITAN Normalized: ribfix titan |
Device | Zimmer Biomet Holdings, Inc. | $103.40 | 1 | 2025 |
Source payment records
|
|||||
| EDWARDS INTUITY ELITE VALVE SYSTEM Normalized: edwards intuity elite valve system |
Device | Edwards Lifesciences Corporation | $101.75 | 1 | 2025 |
Source payment records
|
|||||
| COREVALVE EVOLUT R Normalized: corevalve evolut r |
Device | Medtronic, Inc. | $101.56 | 4 | 2025 |
Source payment records
|
|||||
| ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER Normalized: on x aortic heart valve with conform x sewing ring and extended holder |
Device | Artivion, Inc. | $72.93 | 2 | 2025 |
Source payment records
|
|||||
| ENROUTE Transcarotid Neuroprotection System Normalized: enroute transcarotid neuroprotection system |
Device | Boston Scientific Corporation | $65.33 | 8 | 2025 |
Source payment records
|
|||||
| KONECT RESILIA Normalized: konect resilia |
Device | Edwards Lifesciences Corporation | $58.46 | 3 | 2025 |
Source payment records
|
|||||
| SAPIEN 3 Ultra RESILIA Normalized: sapien 3 ultra resilia |
Device | Edwards Lifesciences Corporation | $56.92 | 1 | 2025 |
Source payment records
|
|||||
| AtriCure cryoICE Cryoablation System (CRYO2) Normalized: atricure cryoice cryoablation system cryo2 |
Device | AtriCure, Inc. | $53.89 | 3 | 2025 |
Source payment records
|
|||||
| PERCEVAL Normalized: perceval |
Device | Corcym Inc | $53.44 | 2 | 2025 |
Source payment records
|
|||||
| HEMOBLAST BELLOWS Normalized: hemoblast bellows |
Device | Dilon Technologies, Inc. | $44.90 | 2 | 2025 |
Source payment records
|
|||||
| XENOSURE BIOLOGIC PATCH Normalized: xenosure biologic patch |
Device | LeMaitre Vascular, Inc. | $38.15 | 2 | 2025 |
Source payment records
|
|||||
| BIOGLUE SURGICAL ADHESIVE Normalized: bioglue surgical adhesive |
Device | Artivion, Inc. | $35.17 | 1 | 2025 |
Source payment records
|
|||||
| KEYTRUDA Normalized: keytruda |
Biological | Merck Sharp & Dohme LLC | $26.52 | 1 | 2025 |
Source payment records
|
|||||
| COOK Normalized: cook |
Device | Cook Medical LLC | $26.31 | 1 | 2025 |
Source payment records
|
|||||
| FIBRYGA Normalized: fibryga |
Biological | Octapharma USA, Inc. | $24.97 | 1 | 2025 |
Source payment records
|
|||||
| COR-KNOT Normalized: cor knot |
Device | LSI SOLUTIONS INC | $20.94 | 1 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $20.91 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH Normalized: zenith |
Device | Cook Medical LLC | $18.19 | 1 | 2025 |
Source payment records
|
|||||
| ANGIOVAC Normalized: angiovac |
Device | AngioDynamics, Inc. | $17.19 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis GraftGuide Normalized: kerecis graftguide |
Device | Kerecis Limited | $16.85 | 1 | 2025 |
Source payment records
|
|||||
| Kerecis SurgiClose Normalized: kerecis surgiclose |
Device | Kerecis Limited | $16.85 | 1 | 2025 |
Source payment records
|
|||||
| MITRIS RESILIA Mitral Valve Normalized: mitris resilia mitral valve |
Device | Edwards Lifesciences Corporation | $16.21 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $13.39 | 1 | 2025 |
Source payment records
|
|||||
| ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM Normalized: atricure cryoice cryosphere cryoablation system |
Device | AtriCure, Inc. | $12.38 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Clopidogrel | Clopidogrel Bisulfate | 17 | 12 |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $4,099.36 · 83 records | INTUITIVE SURGICAL, INC. | AMDS-Ascyrus Medical, ANGIOVAC, ATRICLIP LAA EXCLUSION SYSTEM, ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, AtriCure cryoICE Cryoablation System (CRYO2), BIOGLUE SURGICAL ADHESIVE, COOK, COR-KNOT, COREVALVE EVOLUT R, Da Vinci Surgical System, EDWARDS INTUITY ELITE VALVE SYSTEM, ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent, ESPRIT, FIBRYGA, HEMOBLAST BELLOWS, KEYTRUDA, KONECT RESILIA, Kerecis GraftGuide, Kerecis SurgiClose, MITRIS RESILIA Mitral Valve, NAVITOR, ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER, PERCEVAL, Penumbra System, RIBFIX BLU ADVANTAGE, RIBFIX TITAN, SAPIEN 3 Ultra RESILIA, SYNERGY ABLATION SYSTEM, XACT, XENOSURE BIOLOGIC PATCH, ZENITH | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error